Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
Mã chứng khoánAMIX
Tên công tyAutonomix Medical Inc
Ngày IPOJan 29, 2024
Giám đốc điều hànhHauser (Bradley)
Số lượng nhân viên8
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhJan 29
Địa chỉ21 Waterway Ave, Suite 300
Thành phốTHE WOODLANDS
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện77380
Điện thoại18322777816
Trang webhttps://autonomix.com/
Mã chứng khoánAMIX
Ngày IPOJan 29, 2024
Giám đốc điều hànhHauser (Bradley)
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu